series-a
Stage
1
Investors
About
Phagos Biotech develops AI-enhanced bacteriophage therapies to combat bacterial infections, initially focusing on veterinary applications to reduce antibiotic use in livestock and address antimicrobial resistance.
Explore Phagos Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.